Cesar Alfonso Garcia-Caballero

Dr. Cesar Alfonso Garcia-Caballero

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2026 in Toxics
Verified
Journal Article
Open access
PDF file
CGCesar Alfonso Garcia-Caballero
Cesar Alfonso Garcia-Caballero
JOJosé Luis Ordoñez-Librado
José Luis Ordoñez-Librado
ARAvril De Alba Ríos
Avril De Alba Ríos
EMEnrique Montiel-Flores
Enrique Montiel-Flores
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
MÁMaría Rosa Ávila-Costa
María Rosa Ávila-Costa
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, yet its pathogenic mechanisms remain incompletely understood, highlighting the need for reliable experimental models. We previously developed a murine model based on inhalation of a manganese mixture (MnCl2 and Mn(OAc)3), which reproduces dopaminergic neuron loss in the substantia nigra pars compacta (SNc) and motor impairment. However, its capacity to mimic mitochondrial dysfunction, a key mechanism in PD, had not been explored. This study evaluated mitochondrial ultrastructure, fission and fusion proteins, and the activity of electron transport chain complexes I and IV, alongside fine motor performance. Forty male CD1 mice were divided into control (deionized water) and manganese-exposed groups (0.04 M MnCl2 + 0.02 M Mn(OAc)3), inhaled for 1 h twice weekly over five months. Manganese inhalation induced significant fine motor deficits, increased mitochondrial number with reduced area and circularity, and disorganized cristae. Drp1 and Fis1 levels were elevated, accompanied by decreased activity of complexes I and IV, predominantly in the SNc. These findings demonstrate that this progressive, bilateral model reproduces mitochondrial and motor alterations resembling those observed in PD, supporting its utility for testing mitochondria-targeted therapeutic strategies.

27 November 2024
Verified
Book Chapter
Open access
PDF file
MÁMaría Rosa Ávila-Costa
María Rosa Ávila-Costa
CDClaudia Dorado-Martínez
Claudia Dorado-Martínez
EMEnrique Montiel-Flores
Enrique Montiel-Flores
JOJosé Luis Ordoñez-Librado
José Luis Ordoñez-Librado
AGAna Luisa Gutierrez-Valdez
Ana Luisa Gutierrez-Valdez
PAPatricia Aley-Medina
Patricia Aley-Medina
Chronic exposure to vanadium pentoxide (V2O5) has been linked to neuronal damage equivalent to that found in Alzheimer’s disease (AD). Prior research has indicated that chronic inhalation of V2O5 results in cellular and behavioral changes akin to those observed in AD. A total of 40 male Wistar rats were categorized into two control groups and two experimental groups for the study. The experimental inhaled V2O5 for 6 months; after 6 months, two groups (control and exposed) were left in a 6-month recovery phase. All groups were evaluated monthly for 6 or 12 months in a spatial memory test. To measure histological alterations, hippocampus CA1, entorhinal and frontal cortices, amygdala, and subiculum underwent Congo red or argentic Bielschowsky impregnation and were analyzed. Memory results show impairment since the third month. The group left in recovery did not show improvement. Chronic V2O5 inhalation is an AD model that causes irreversible alterations in spatial memory, accumulation of Aβ plaques, accumulation of NFTs, and loss of dendritic spines with no recovery. These alterations are not reversible after 6 months, indicating that the damage increases once the neurodegenerative process is established and the homeostasis is broken. This model characterizes sporadic AD, representing more than 95% of cases.